This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gonias, S. L. Articles by Hoffman, M. Search for Related Content PubMed PubMed Citation Articles by Gonias, S. L. Articles by Hoffman, M.

Clearance and Distribution of Recombinant Murine -Interferon in Mice¹

Departments of Pathology and Biochemistry, University of Virginia Medical Center, Charlottesville, Virginia 22908 [S. L. G.]; the Departments of Pathology and Biochemistry, Duke University Medical Center, Durham, North Carolina 27710 [S. V. P.]; and the Department of Laboratory Medicine, Veterans Administration Medical Center, Durham, North Carolina 27705 [M. H.]

Recombinant murine -interferon (rIFN-) was radiolabeled by a novel procedure which does not require the use of preiodinated Bolton-Hunter reagent (specific activities of 0.5–3.0 µCi/µg). Gel filtration chromatography of the radiolabeled preparation yielded two peaks. The early eluting peak contained disulfide stabilized aggregates with minimal interferon antiviral activity. The second peak contained activity that was consistently greater than or equal to that of the nonradiolabeled rIFN-. Two bands with apparent molecular weights of 17,000 and 34,000 were observed when the second peak was analyzed by SDS gel electrophoresis. Fractions comprising each of the two chromatography peaks were pooled separately and subjected to gel filtration again on identical columns 24 h after completion of the first column run. The elution volumes of each peak remained unchanged suggesting that the two forms are not in rapid equilibrium. The plasma clearance rates of [¹²⁵I]rIFN- before and after purification by chromatography were initially rapid but multiphasic. The slower phases of clearance did not result from stable association of the rIFN- with plasma proteins. In organ distribution studies, the liver and spleen sequestered significant amounts of [¹²⁵I]rIFN-; however, the highest concentration of rIFN- was recovered in the kidneys. A functional nephrectomy procedure was used to further study the role of the kidneys in rIFN- clearance. Eliminating the kidneys significantly increased the amount of rIFN- retained in the circulation, particularly at later times when the vascular [¹²⁵I]rIFN- levels were approximately threefold higher than in nonnephrectomized mice.

¹ Supported in part by the American Cancer Society program on interferon [S. L. G.] and by the Veterans Administration Career Development Program [M. H.]. This work was also supported by National Cancer Institute Grant Ca29589 and Grant 1690 from the Council for Tobacco Research.

² To whom requests for reprints should be addressed, at University of Virginia Medical Center, Department of Pathology, Box 214, Charlottesville, VA 22908.

Received 8/31/87. Revised 12/29/87. Accepted 1/19/88.

This article has been cited by other articles:

				S. C. Whitman, P. Ravisankar, H. Elam, and A. Daugherty Exogenous Interferon-{{gamma}} Enhances Atherosclerosis in Apolipoprotein E-/- Mice Am. J. Pathol., December 1, 2000; 157(6): 1819 - 1824. [Abstract] [Full Text] [PDF]